If you are a sales professional or want to become one, or if you are looking for a new sales job, you will face one of the toughest interview processes of any job seeker.
New line of natural infection control products for caregivers and patients ATLANTA–(HSMN NewsFeed)–Vystar Corporation and Alatech Healthcare, LLC announced 510(k) clearance from the U.S. Food and Drug Administration (FDA) to market and sell the first …
Devices, FDA
Vystar, Alatech Healthcare, Vytex
Posts from ‘July, 2009’
Vystar(R) Corporation and Alatech Healthcare, LLC Announce FDA 510(k) Clearance for Exam Gloves Made with Vytex(R) NRL
Akebia Completes $16M Expansion of Series A Financing
Increases Total Series A Round to $25M CINCINNATI - (HSMN NewsFeed) - Akebia Therapeutics, Inc., a tiny molecule discovery and development company focused on anemia and vascular disorders, today announced that it has increased its previously announced …
Biopharmaceuticals, Venture Capital
Akebia Therapeutics, AKB-6548, anemia
MULTAQ(R) (dronedarone) for Atrial Fibrillation or Atrial Flutter Now Available in the United States
New treatment option to reduce cardiovascular hospitalization in patients with atrial fibrillation (AF) or atrial flutter (AFL) BRIDGEWATER, N.J., July 28 (HSMN NewsFeed) — Sanofi-aventis (EURONEXT: SAN and NYSE: SNY) announced today that MULTAQ(R) (…
Biopharmaceuticals, Cardiology
sanofi-aventis, MULTAQ, dronedarone, atrial fibrillation, atrial flutter
Watson CFO Mark W. Durand to Take Leave of Absence
MORRISTOWN, N.J., July 27 (HSMN NewsFeed) — Watson Pharmaceuticals, Inc. (NYSE: WPI ), a leader in generic and specialty branded pharmaceuticals, announced that effective today Mark W. Durand, Senior Vice President and Chief Financial Officer, has taken…
Biopharmaceuticals, Personnel
Watson Pharmaceuticals
Custom Spine Announces New Board of Directors and CFO
PARSIPPANY, N.J., July 27 (HSMN NewsFeed) — To further strengthen the company’s leadership and future outlook, Custom Spine announces new members to the Board of Directors. Over the past several months Custom Spine, under the leadership of President Lew…
Devices, Orthopaedic, Neurosurgery, Personnel
Custom Spine
Amgen to Collaborate With GlaxoSmithKline to Commercialize Denosumab in Europe for Postmenopausal Osteoporosis (PMO)
Amgen to Retain Full Rights for Denosumab in the United States and Canada and for Oncology Indications in Europe GlaxoSmithKline Will Commercialize Denosumab for PMO and Oncology in Emerging Markets THOUSAND OAKS, Calif. and LONDON, July 27 (HSMN NewsF…
Biopharmaceuticals
Amgen, GlaxoSmithKline, denosumab, postmenopausal osteoporosis
Paradigm Spine Closes $21.5 Million Financing and Announces Promotion of Matt Stuttle to Job of Vice President, US Revenue
NEW YORK–(HSMN NewsFeed)–Paradigm Spine, LLC, a developer of innovative non-fusion spinal implant solutions, announced that it has completed a $21.5 million financing, consisting of a $15mm debt facility and $6.5mm equity. Fifth Third Bank was the sole l…
Devices, Orthopaedic, Neurosurgery, Personnel
Paradigm Spine
Accuray Announces CyberKnife Access Remote Service Product
Purchase of Axeda ServiceLink Solution Enables Fast and Effective Servicing SUNNYVALE, Calif., July 26 (HSMN NewsFeed) — Accuray Incorporated (Nasdaq: ARAY ), a global leader in the field of radiosurgery, announced today the launch of the CyberKnife …
Devices, Oncology
Accuray, CyberKnife, CyberKnife Access, Axeda, radiosurgery, radiotherapy
Cyberonics Provides Update on Depression Post-Approval Study
HOUSTON, July 24 (HSMN NewsFeed) — Cyberonics, Inc. (Nasdaq: CYBX ) today announced that the U.S. Food and Drug Administration ("FDA") has approved the company’s proposal to amend the protocol of its D-21 post-approval dosing study in depressi…
Devices, Neurology, FDA
Cyberonics, VNS Therapy, neuromodulation, depression
United States Patent and Trademark Office Confirms Validity of KCI Negative Pressure Wound Therapy Patents
SAN ANTONIO–(HSMN NewsFeed)–Kinetic Concepts, Inc. (NYSE: KCI ) today announced that the U.S. Patent and Trademark Office (USPTO) issued Office actions confirming the validity of three separate patents licensed to KCI by Wake Forest University Health Sci…
Devices, Wound Care
Kinetic Concepts, Negative Pressure Wound Therapy, V.A.C. Therapy
